Biblio Discovery — Demo Discovery Service

10 results for "Federico Corelli"

Showing 1–10 · 0.21 seconds · RSS

  1. Journal Article Full text

    The Selective CB2 Agonist COR167 Reduced Symptoms in a Mice Model of Trauma-Induced Peripheral Neuropathy through HDAC-1 Inhibition

    Vittoria Borgonetti; Claudia Mugnaini; Federico Corelli et al.

    Biomedicines, Vol. 11 No. 6 · 2023 · English · DOAJ Scopus

    Neuropathic pain is a chronic disabling condition with a 7–10% of prevalence in the general population that is largely undertreated. Available analgesic therapies are poorly effective and are often accompanied by numerous side effects. Growing evidence indicates cannabinoids are a valuable…

  2. Journal Article Full text

    In Silico Multi-Target Approach Revealed Potential Lead Compounds as Scaffold for the Synthesis of Chemical Analogues Targeting SARS-CoV-2

    Alfonso Trezza; Claudia Mugnaini; Federico Corelli et al.

    Biology, Vol. 11 No. 3 · 2022 · English · DOAJ Scopus

    Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), an infectious disease that spreads rapidly in humans. In March 2020, the World Health Organization (WHO) declared a COVID-19 pandemic. Identifying a multi-target-directed ligand approach would…

  3. Journal Article Full text

    Indole-2-Carboxamide as an Effective Scaffold for the Design of New TRPV1 Agonists

    Samuele Maramai; Claudia Mugnaini; Marco Paolino et al.

    Molecules, Vol. 30 No. 3 · 2025 · English · DOAJ Scopus

    Due to its central role in pain, inflammation, and related disorders, the Transient Receptor Potential (TPR) Vanilloid Type-1 (TRPV1) ion channel represents an attractive target for the development of novel antinociceptive and anti-inflammatory agents. Capsaicin, the natural component of chili…

  4. Journal Article

    Reduction by the positive allosteric modulator of the GABAB receptor, GS39783, of alcohol self-administration in Sardinian alcohol-preferring rats exposed to the “sipper” procedure

    Paola Maccioni; Paolo Flore; Mauro A M Carai et al.

    Frontiers in Psychiatry, Vol. 1 · 2010 · English · DOAJ Scopus

    The present study was designed to evaluate (a) alcohol self-administration behavior of selectively bred, Sardinian alcohol-preferring (sP) rats exposed to the so-called “sipper” procedure (characterized by the temporal separation between alcohol-seeking and -taking phases), and (b) the effect of…

  5. Journal Article Full text

    Investigation on Novel E/Z 2-Benzylideneindan-1-One-Based Photoswitches with AChE and MAO-B Dual Inhibitory Activity

    Marco Paolino; Modesto de Candia; Rosa Purgatorio et al.

    Molecules, Vol. 28 No. 15 · 2023 · English · DOAJ Scopus

    The multitarget therapeutic strategy, as opposed to the more traditional ‘one disease-one target-one drug’, may hold promise in treating multifactorial neurodegenerative syndromes, such as Alzheimer’s disease (AD) and related dementias. Recently, combining a photopharmacology approach with the…

  6. Journal Article Full text

    Optimization of Pyrazole Compounds as Antibiotic Adjuvants Active against Colistin- and Carbapenem-Resistant Acinetobacter baumannii

    Filomena Sannio; Antonella Brizzi; Rosita Del Prete et al.

    Antibiotics, Vol. 11 No. 12 · 2022 · English · DOAJ Scopus

    The diffusion of antibiotic-resistant, Gram-negative, opportunistic pathogens, an increasingly important global public health issue, causes a significant socioeconomic burden. Acinetobacter baumannii isolates, despite causing a lower number of infections than Enterobacterales, often show…

  7. Journal Article Full text

    Systematic Modification of the Substitution Pattern of the 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Scaffold Enabled the Discovery of New Ligands with High Affinity and Selectivity for the Cannabinoid Type 2 Receptor

    Claudia Mugnaini; Magdalena Kostrzewa; Marta Casini et al.

    Molecules, Vol. 28 No. 13 · 2023 · English · DOAJ Scopus

    Selective ligands of the CB2 receptor are receiving considerable attention due to their potential as therapeutic agents for a variety of diseases. Recently, 7-hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide derivatives were shown to act at the CB2 receptor either as agonists or as inverse…